Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy

被引:44
|
作者
Kauffman, Eric C. [1 ]
Ng, Casey K. [1 ]
Lee, Ming Ming [1 ]
Otto, Brandon J. [1 ]
Wang, Gerald J. [1 ]
Scherr, Douglas S. [1 ]
机构
[1] New York Presbyterian Hosp, Dept Urol, Weill Cornell Med Ctr, New York, NY 10065 USA
关键词
bladder; carcinoma; lymph node; robotic-assisted radical cystectomy; CANCER-SPECIFIC SURVIVAL; LYMPH-NODE DISSECTION; URINARY-DIVERSION; PELVIC LYMPHADENECTOMY; RISK-FACTORS; RECURRENCE; MORBIDITY; DENSITY; IMPACT;
D O I
10.1111/j.1464-410X.2010.09577.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine oncological outcomes including early survival rates among unselected bladder urothelial carcinoma (BUC) patients treated with robotic-assisted radical cystectomy (RRC). PATIENTS AND METHODS Clinicopathologic and survival data were prospectively gathered for 85 consecutive BUC patients treated with RRC. The decision to undergo a robotic rather than open approach was made without regard to tumor volume or surgical candidacy. Kaplan-Meier survival rates were determined and stratified by tumor stage and LN positivity, and multivariate analysis was performed to identify independent predictors of survival. RESULTS Patients were relatively old (25% > 80 years; median 73.5 years), with frequent comorbidities (46% with ASA class >= 3). Of these patients 28% had undergone previous pelvic radiation or pelvic surgery, and 20% had received neoadjuvant chemotherapy. Extended pelvic lymphadenectomy was performed in 98% of patients, with on average 19.1 LN retrieved. On final pathology, extravesical disease was common (36.5%). Positive surgicalmargins were detected in five (6%) patients, all of whom had extravesical tumors with perineural and/or lymphovascular invasion, and most of whom were > 80 years old. At a mean postoperative interval of 18 months, 20 (24%) patients had developed recurrent disease, but only three (4%) patients had recurrence locally. Disease-free, cancer-specific and overall survival rates at 2 years were 74%, 85% and 79%, respectively. Patients with low-stage/LN(-) cancers had significantly better survival than extravesical/LN(-) or any-stage/LN(+) patients, with stage being the most important predictor on multivariate analysis. CONCLUSION RRC can achieve adequately high LN yields with a low positive margin rate among unselected BUC patients. Early survival outcomes are similar to those reported in contemporary open series, with an encouragingly low incidence of local recurrence, however long-term follow-up and head-to-head comparison with the open approach are still needed.
引用
收藏
页码:628 / 635
页数:8
相关论文
共 50 条
  • [1] The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
    Takemoto, Kenshiro
    Teishima, Jun
    Kohada, Yuki
    Ikeda, Kenichiro
    Nagamatsu, Hirotaka
    Goriki, Akihiro
    Inoue, Shogo
    Hayashi, Tetsutaro
    Kajiwara, Mitsuru
    Matsubara, Akio
    ANTICANCER RESEARCH, 2020, 40 (08) : 4787 - 4793
  • [2] IMPACT OF STATIN USE ON ONCOLOGICAL OUTCOMES OF PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY
    Donalisio-da-Silva, Rodrigo
    Xylinas, Evanguelos
    Kluth, Luis
    Crivelli, Joseph
    Chade, Daher
    Guglielmetti, Giuliano
    Lotan, Yair
    Karakiewicz, Pierre
    Sun, Maxine
    Pycha, Armin
    Montorsi, Francesco
    Zerbib, Marc
    Scherr, Douglas
    Shariat, Shahrokh
    JOURNAL OF UROLOGY, 2013, 189 (04): : E584 - E585
  • [3] Variant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy
    Hazir, Berk
    Haberal, Hakan Bahadir
    Baltaci, Kadir Emre
    Shahsuvarli, Parviz
    Akdogan, Bulent
    Bilen, Cenk Yucel
    Yazici, Mustafa Sertac
    JOURNAL OF UROLOGICAL SURGERY, 2021, 8 (04): : 243 - 247
  • [4] Robotic-assisted laparoscopic radical cystectomy: Surgical and oncological outcomes
    Treiyer, Adrian
    Saar, Matthias
    Buetow, Zentia
    Kamradt, Joern
    Siemer, Stefan
    Stoeckle, Michael
    INTERNATIONAL BRAZ J UROL, 2012, 38 (03): : 324 - 329
  • [5] Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?
    Soave, Armin
    Schmidt, Selina
    Dahlem, Roland
    Minner, Sarah
    Engel, Oliver
    Kluth, Luis A.
    John, Lisa-Marie
    Hansen, Jens
    Schmid, Marianne
    Sauter, Guido
    Shariat, Shahrokh F.
    Fisch, Margit
    Rink, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 21.e1 - 21.e9
  • [6] Feasibility and Outcomes of Robotic-assisted Laparoscopic Radical Cystectomy for Bladder Cancer in Older Patients
    Coward, Robert M.
    Smith, Angela
    Raynor, Mathew
    Nielsen, Matthew
    Wallen, Eric M.
    Pruthi, Raj S.
    UROLOGY, 2011, 77 (05) : 1111 - 1114
  • [7] Initial outcomes of robotic assisted radical cystectomy for bladder carcinoma
    Hui, N. S.
    Wei, L. Y.
    Christopher, C. W. S.
    Henry, H. S. S.
    Shiong, L. L.
    BJU INTERNATIONAL, 2015, 115 : 33 - 33
  • [8] PERIOPERATIVE AND ONCOLOGICAL OUTCOMES OF OBESE PATIENTS WITH BLADDER CANCER UNDERGOING ROBOTIC ASSISTED RADICAL CYSTECTOMY
    Ahmadi, Nariman
    Roeter, Daniel
    Shin, Toshitaka
    Miranda, Gus
    Cai, Jie
    Aron, Monish
    Desai, Mihir
    Gill, Inderbir
    JOURNAL OF UROLOGY, 2016, 195 (04): : E667 - E668
  • [9] Robotic assisted laparoscopic radical cystectomy for bladder carcinoma: early experience and oncologic outcomes
    Tsui, Ke-Hung
    Chen, Chien-Lun
    Lin, Yu-Hsiang
    Hou, Chen-Pang
    Chang, Phei-Lang
    FORMOSAN JOURNAL OF SURGERY, 2012, 45 (06) : 178 - 182
  • [10] Oncological outcomes of robotic-assisted radical hysterectomy
    Buderath, Paul
    Kimmig, Rainer
    MINERVA GINECOLOGICA, 2016, 68 (01): : 43 - 48